$SODI
SOLITRON DEVICES INC Stock $sodi

$sodi Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-K Financial Statement

#000165495422009676 Filed on July 14, 2022

Income Statement

Concept	2022 Q1	2022	2021 Q1
Revenue	$1.976M	$12.28M	$2.621M
YoY Change	-24.61%	16.61%	31.25%
Cost Of Revenue	$1.857M	$7.485M	$1.838M
YoY Change	1.03%	3.14%	12.35%
Gross Profit	$119.0K	$4.799M	$783.0K
YoY Change	-84.8%	46.44%	116.9%
Gross Profit Margin	6.02%	39.07%	29.87%
Selling, General & Admin	$637.0K	$2.507M	$521.0K
YoY Change	22.26%	18.93%	-7.95%
% of Gross Profit	535.29%	52.24%	66.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$71.00K	$264.0K	$46.00K
YoY Change	54.35%	17.33%	-19.3%
% of Gross Profit	59.66%	5.5%	5.87%
Operating Expenses	$637.0K	$2.507M	$521.0K
YoY Change	22.26%	18.93%	-7.95%
Operating Profit	-$518.0K	$2.292M	$262.0K
YoY Change	-297.71%	96.07%	-227.8%
Interest Expense	-$42.00K	$103.0K	$66.00K
YoY Change	-163.64%	1960.0%	186.96%
% of Operating Profit		4.49%	25.19%
Other Income/Expense, Net	$101.0K	$17.00K	$76.00K
YoY Change	32.89%
Pretax Income	-$459.0K	$3.508B	$404.0K
YoY Change	-213.61%	154.02%	-321.98%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings	-$459.0K	$3.508M	$404.0K
YoY Change	-213.61%	154.02%	-321.98%
Net Earnings / Revenue	-23.23%	28.56%	15.41%
Basic Earnings Per Share
Diluted Earnings Per Share	-$220.3K	$1.684M	$193.9K
COMMON SHARES
Basic Shares Outstanding	2.083M shares		2.083M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q1	2022	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.772M	$4.772M	$4.033M
YoY Change	18.32%	18.32%	169.59%
Cash & Equivalents	$4.088M	$4.088M	$3.785M
Short-Term Investments	$684.0K	$684.0K	$248.0K
Other Short-Term Assets	$196.0K	$196.0K	$372.0K
YoY Change	-47.31%	-47.31%	215.25%
Inventory	$2.260M	$2.260M	$2.721B
Prepaid Expenses
Receivables	$1.591M	$1.591M	$1.306M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.819M	$8.819M	$8.432M
YoY Change	4.59%	4.59%	43.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.926M	$5.535M	$281.0K
YoY Change	1653.02%	791.3%	-75.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.000K	$4.000K	$40.00K
YoY Change	-90.0%	-90.0%	-11.11%
Total Long-Term Assets	$5.539M	$5.539M	$661.0K
YoY Change	737.97%	737.97%	-43.65%
TOTAL ASSETS
Total Short-Term Assets	$8.819M	$8.819M	$8.432M
Total Long-Term Assets	$5.539M	$5.539M	$661.0K
Total Assets	$14.36M	$14.36M	$9.093M
YoY Change	57.9%	57.9%	29.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$135.0K	$135.0K	$165.0K
YoY Change	-18.18%	-18.18%	-38.66%
Accrued Expenses	$888.0K	$872.0K	$740.0K
YoY Change	20.0%	-21.93%	-13.35%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$112.0K	$112.0K	$52.00K
YoY Change	115.38%	115.38%
Total Short-Term Liabilities	$1.159M	$1.159M	$1.383M
YoY Change	-16.2%	-16.2%	17.6%
LONG-TERM LIABILITIES
Long-Term Debt	$2.755M	$2.758M	$0.00
YoY Change		254.95%
Other Long-Term Liabilities			$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$2.755M	$2.758M	$0.00
YoY Change		254.95%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.159M	$1.159M	$1.383M
Total Long-Term Liabilities	$2.755M	$2.758M	$0.00
Total Liabilities	$3.917M	$3.917M	$2.160M
YoY Change	81.34%	81.34%	39.09%
SHAREHOLDERS EQUITY
Retained Earnings	$9.998M		$6.490M
YoY Change	54.05%
Common Stock	$1.855M		$1.855M
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.412M		$1.412M
YoY Change	0.0%
Treasury Stock Shares	487.8K shares		487.8K shares
Shareholders Equity	$10.44M	$10.44M	$6.933M
YoY Change
Total Liabilities & Shareholders Equity	$14.36M	$14.36M	$9.093M
YoY Change	57.9%	57.9%	29.24%

Cashflow Statement

Concept	2022 Q1	2022	2021 Q1
OPERATING ACTIVITIES
Net Income	-$459.0K	$3.508M	$404.0K
YoY Change	-213.61%	154.02%	-321.98%
Depreciation, Depletion And Amortization	$71.00K	$264.0K	$46.00K
YoY Change	54.35%	17.33%	-19.3%
Cash From Operating Activities	-$116.0K	$3.334M	$247.0K
YoY Change	-146.96%	99.16%	-21.59%
INVESTING ACTIVITIES
Capital Expenditures	-$750.0K	$4.890M	-$7.000K
YoY Change	10614.29%	6420.0%	-72.0%
Acquisitions
YoY Change
Other Investing Activities	-$268.0K	-$390.0K	$92.00K
YoY Change	-391.3%	-835.85%	-217.95%
Cash From Investing Activities	-$1.018M	-$5.889M	$85.00K
YoY Change	-1297.65%	26668.18%	-182.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-25.00K	$2.858M	0.000
YoY Change		256.8%
NET CHANGE
Cash From Operating Activities	-116.0K	$3.334M	247.0K
Cash From Investing Activities	-1.018M	-$5.889M	85.00K
Cash From Financing Activities	-25.00K	$2.858M	0.000
Net Change In Cash	-1.159M	$303.0K	332.0K
YoY Change	-449.1%	-87.65%	56.6%
FREE CASH FLOW
Cash From Operating Activities	-$116.0K	$3.334M	$247.0K
Capital Expenditures	-$750.0K	$4.890M	-$7.000K
Free Cash Flow	$634.0K	-$1.556M	$254.0K
YoY Change	149.61%	-197.31%	-25.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Interest Expense InterestExpense	103000	USD
CY2021	us-gaap	Interest Expense InterestExpense	5000	USD
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	36000	USD
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	812000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2022	sodi	Scrap Income ScrapIncome	441000	USD
CY2021	sodi	Scrap Income ScrapIncome	76000	USD
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	17000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2022	us-gaap	Other Income OtherIncome	1216000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	1381000	USD
CY2022	sodi	Net Income Per Common Share Basic And Diluted NetIncomePerCommonShareBasicAndDiluted	1.68
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	13000	USD
CY2021	sodi	Net Income Per Common Share Basic And Diluted NetIncomePerCommonShareBasicAndDiluted	0.67
CY2022	sodi	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	2083453	shares
CY2021	sodi	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	2067829	shares
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	5483000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	1381000	USD
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	264000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	225000	USD
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6000	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	75000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	1381000	USD
CY2022	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	340000	USD
CY2021	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	383000	USD
CY2022	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	-44000	USD
CY2021	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	-134000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	2160000	USD
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	75000	USD
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2022	sodi	Ppp Loan Forgiveness PppLoanForgiveness	-812000	USD
CY2021	sodi	Ppp Loan Forgiveness PppLoanForgiveness	0	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	6933000	USD
CY2022	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-17000	USD
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
CY2022	sodi	Transfer Agent Adjustment Of Common Stock Amount TransferAgentAdjustmentOfCommonStockAmount	0	USD
CY2021	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	USD
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-285000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	73000	USD
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	461000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	149000	USD
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2022	dei	Auditor Location AuditorLocation	Houston, Texas
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	684000	USD
CY2022Q1	sodi	Inventories Net InventoriesNet	2260000	USD
CY2021Q1	sodi	Inventories Net InventoriesNet	2721000	USD
CY2022Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	609000	USD
CY2021Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	0	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	340000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	377000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9000	USD
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2021Q1	us-gaap	Notes Payable Current NotesPayableCurrent	43000	USD
CY2022Q1	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	103000	USD
CY2021Q1	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	0	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	740000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1383000	USD
CY2022Q1	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	0	USD
CY2021Q1	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	764000	USD
CY2022Q1	sodi	Mortgage Loan Net Of Current MortgageLoanNetOfCurrent	2755000	USD
CY2021Q1	sodi	Mortgage Loan Net Of Current MortgageLoanNetOfCurrent	0	USD
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	176000	USD
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2083436	shares
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	487827	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	21000	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	21000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-254000	USD
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	36000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1834000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1834000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	9998000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6490000	USD
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1412000	USD
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1412000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	10441000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	6933000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14358000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9093000	USD
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	68000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	98000	USD
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-24000	USD
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3508000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	10441000	USD
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3508000	USD
CY2022	us-gaap	Gross Profit GrossProfit	4799000	USD
CY2021	us-gaap	Gross Profit GrossProfit	3277000	USD
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2507000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2108000	USD
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2083462	shares
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	487801	shares
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	2292000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	1169000	USD
CY2022	us-gaap	Dividend Income Operating DividendIncomeOperating	5000	USD
CY2021	us-gaap	Dividend Income Operating DividendIncomeOperating	7000	USD
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3334000	USD
CY2022	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-25000	USD
CY2021	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-4000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5000	USD
CY2022	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-377000	USD
CY2021	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-417000	USD
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-9000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-30000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-104000	USD
CY2022	sodi	Accrued Expenses Other Current And Non Current Liabilities AccruedExpensesOtherCurrentAndNonCurrentLiabilities	148000	USD
CY2021	sodi	Accrued Expenses Other Current And Non Current Liabilities AccruedExpensesOtherCurrentAndNonCurrentLiabilities	296000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2453000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1674000	USD
CY2022	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	270000	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	530000	USD
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	660000	USD
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	477000	USD
CY2022	sodi	Expenditures On Construction In Progress ExpendituresOnConstructionInProgress	-609000	USD
CY2021	sodi	Expenditures On Construction In Progress ExpendituresOnConstructionInProgress	0	USD
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4890000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	75000	USD
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5889000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22000	USD
CY2022	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	2940000	USD
CY2021	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	807000	USD
CY2022	us-gaap	Payments For Loans PaymentsForLoans	82000	USD
CY2021	us-gaap	Payments For Loans PaymentsForLoans	0	USD
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6000	USD
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2858000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	801000	USD
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	303000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3785000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1332000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4088000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3785000	USD
CY2022	us-gaap	Property Plant And Equipment Gross Period Increase Decrease PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease	0	USD
CY2021	us-gaap	Property Plant And Equipment Gross Period Increase Decrease PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease	26000	USD
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2022	us-gaap	Interest Paid InterestPaid	102000	USD
CY2021	us-gaap	Interest Paid InterestPaid	0	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.000	pure
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	888000	USD
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	740000	USD
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The financial statements are prepared in accordance with U.S. GAAP. Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. The Company could have reasonably used different accounting estimates. This applies in particular to inventory and valuation allowance for deferred tax assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial statement presentation, financial condition, results of operations and cash flows will be affected. The ultimate impact from COVID-19 on the Company’s operations and financial results during fiscal 2023 will depend on, among other things, the ultimate severity and scope of the pandemic, the pace at which governmental and private travel restrictions and public concerns about public gatherings will ease, and the speed with which the economy recovers. The Company is not able to fully quantify the impact that these factors will have on the Company’s financial results during fiscal 2023 and beyond. The Company believes COVID-19 had a negative impact on the Company’s bookings in fiscal 2022, which will negatively impact fiscal 2023 net sales.</p>
CY2022	sodi	One Security Valued OneSecurityValued	44800	USD
CY2022	sodi	Second Security Valued SecondSecurityValued	24000	USD
CY2022Q1	sodi	Deferred Tax Liability Related To Unrecognized Gains And Losses On Short Term Investments DeferredTaxLiabilityRelatedToUnrecognizedGainsAndLossesOnShortTermInvestments	0	USD
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments, which potentially subject the Company to concentration of credit risk, consist principally of cash and account receivables. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The Company has not experienced any losses in such accounts and believes that it is not exposed to any significant credit risk on the accounts. As of February 28, 2022, and February 28, 2021, all non-interest bearing checking accounts were FDIC insured to a limit of $250,000. Deposits in excess of FDIC insured limits were approximately $3,448,000 at February 28, 2022 and $2,757,000 at February 28, 2021. With respect to the account receivables, most of the Company’s products are custom made pursuant to contracts with customers whose end-products are sold to the United States Government. The Company performs ongoing credit evaluations of its customers’ financial condition and maintains allowances for potential credit losses. Actual losses and allowances have historically been within management’s expectations. </p>
CY2022	sodi	Financial Statement Estimates FinancialStatementEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates and the differences could be material. Such estimates include variable consideration related to revenue recognition, stock-based compensation, depreciable life of property and equipment, accounts receivable allowance, deferred tax valuation allowance, and allowance for inventory obsolescence.</p>
CY2022	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company capitalizes all leased assets pursuant to ASU 2016-02, “Leases (Topic 842),” which requires lessees to recognize right-of-use assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases. The Company excludes short-term leases having initial terms of 12 months or less from Topic 842 as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term.</p>
CY2022	us-gaap	Revenue Recognition Sales Returns RevenueRecognitionSalesReturns	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">February 28, 2022</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">February 28, 2021</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Beginning Balance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">354,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">126,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued Allowances</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">117,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">228,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Credits Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Ending Balance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">471,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">354,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q1	us-gaap	Inventory Net InventoryNet	2260000000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	2721000000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9860000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4395000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4325000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4114000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	281000	USD
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	264000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	225000	USD
CY2022Q1	sodi	Bonus Accrual BonusAccrual	0	USD
CY2021Q1	sodi	Bonus Accrual BonusAccrual	70000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-340000000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.246	pure
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3508000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1381000000	USD
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	737000000	USD
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	290000000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	56000000	USD
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.016	pure
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	50000000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.036	pure
CY2022	sodi	Permanent Book Tax Differences PermanentBookTaxDifferences	-170000000	USD
CY2022	sodi	Effective Income Tax Rate Permanent Book Tax Difference EffectiveIncomeTaxRatePermanentBookTaxDifference	-0.048	pure
CY2021	sodi	Permanent Book Tax Differences PermanentBookTaxDifferences	0	USD
CY2021	sodi	Effective Income Tax Rate Permanent Book Tax Difference EffectiveIncomeTaxRatePermanentBookTaxDifference	0.000	pure
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-623000000	USD
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.178	pure
CY2022	sodi	True Up And Adjustments TrueUpAndAdjustments	0	USD
CY2022	sodi	True Up And Adjustments Percentage TrueUpAndAdjustmentsPercentage	0.000	pure
CY2021	sodi	True Up And Adjustments TrueUpAndAdjustments	0	USD
CY2021	sodi	True Up And Adjustments Percentage TrueUpAndAdjustmentsPercentage	0.000	pure
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	USD
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.000	pure
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	49000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	57000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1363000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1406000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	USD
CY2021Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	54000	USD
CY2022Q1	sodi	Federal Net Operating Loss Carryforward Expiration2029 FederalNetOperatingLossCarryforwardExpiration2029	322000000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	1254000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	9090000000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2065000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2456000	USD
CY2022	sodi	Cares Act Net Operating Loss Carryforwards Offset Taxable Income Percentage CARESActNetOperatingLossCarryforwardsOffsetTaxableIncomePercentage	1	pure
CY2022	sodi	Recovery Period RecoveryPeriod	P15Y
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	9100000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	6200000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	10100000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	9300000	USD
CY2022Q1	sodi	Federal Net Operating Loss Carryforward Expiration2023 FederalNetOperatingLossCarryforwardExpiration2023	7514000000	USD
CY2022Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	14000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	15000	USD
CY2022Q1	sodi	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation	-132000	USD
CY2021Q1	sodi	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation	-6000	USD
CY2022Q1	sodi	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	3359000	USD
CY2021Q1	sodi	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	3982000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3359000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3982000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3359000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3982000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	USD
CY2022	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.86	pure
CY2021	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.75	pure
CY2021Q1	sodi	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	340000	USD
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	340000	USD
CY2022Q1	sodi	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	0	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2020Q1	sodi	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	723000	USD
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	383000	USD
CY2021Q1	sodi	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	340000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	377000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	377000	USD
CY2022	sodi	Rent Expense Paid RentExpensePaid	457000	USD
CY2021	sodi	Rent Expense Paid RentExpensePaid	484000	USD
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	1000000.0	USD
CY2022	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	16	shares
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2493	shares

Files In Submission

Name	View Source	Status
0001654954-22-009676-index-headers.html	Edgar Link	pending
0001654954-22-009676-index.html	Edgar Link	pending
0001654954-22-009676.txt	Edgar Link	pending
0001654954-22-009676-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sodi-20220228.xsd	Edgar Link	pending
sodi-20220228_cal.xml	Edgar Link	unprocessable
sodi-20220228_def.xml	Edgar Link	unprocessable
sodi-20220228_lab.xml	Edgar Link	unprocessable
sodi-20220228_pre.xml	Edgar Link	unprocessable
sodi_10k.htm	Edgar Link	pending
sodi_10k_htm.xml	Edgar Link	completed
sodi_ex231.htm	Edgar Link	pending
sodi_ex31.htm	Edgar Link	pending
sodi_ex32.htm	Edgar Link	pending
sodi_ex41.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SODI
SOLITRON DEVICES INC Stock $sodi

2022 Q1 Form 10-K Financial Statement

#000165495422009676 Filed on July 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SODI SOLITRON DEVICES INC Stock $sodi

2022 Q1 Form 10-K Financial Statement

#000165495422009676 Filed on July 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SODI
SOLITRON DEVICES INC Stock $sodi